Trademarkia Logo

Canada

C$
Trademark Search in Canada
AQVESME

View On IC.GC.CA

AQVESME
CANCELLED

Last Applicant/ Owned by

AGIOS PHARMACEUTICALS INC.

88 Sidney StreetCambridge MA 02139-4169

US

Serial Number

2033292 filed on 11th Jan 2020

Registration Number

TMA1163231 registered on 1st Feb 2023

Registration expiry Date

11th Jan 2030

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

AQVESME

Trademark usage description

pharmaceutical products for the prevention and treatment of blood disorders; pharmaceutical products for the prevention and treatment of sickle cell d Read More

Classification Information

Class [005]
Pharmaceutical products for the prevention and treatment of blood disorders; pharmaceutical products for the prevention and treatment of sickle cell disease, polycystic kidney disease (PKD) and beta thalassemia; pharmaceutical products for the prevention and treatment of rare genetic diseases effecting red blood cells; pharmaceutical products for the prevention and treatment of various anemias

Classification kind code

11

Mark Details

Serial Number

2033292

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 22nd Nov 2021		Agent Changed
Submitted for opposition 22
on 17th Sept 2021		Search Recorded
Submitted for opposition 20
on 17th Sept 2021		Examiner's First Report
Submitted for opposition 223
on 17th Sept 2021		Total Provisional Refusal
Submitted for opposition 256
on 12th Apr 2021		Notification of Possible Opposition Sent
Submitted for opposition 257
on 11th Jun 2020		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 10th Jun 2020		Created
Submitted for opposition 31
on 10th Jun 2020		Formalized
Submitted for opposition 30
on 11th Jan 2020		Filed
Submitted for opposition 228
on 11th Jan 2020		International Registration